|
|||||
|
|
Indirect comparison and cost-utility of dabigatran etexilate and rivaroxaban in the treatment and extended anticoagulation of venous thromboembolism in a UK setting |
|
| Authors: | Anamaria Vera Jugrin Volker Hösel Anastasia Ustyugova Maria De Francesco Tom Sunderland |
| Institution: | 1. IMS HEOR, Vilvoorde, Belgium;2. StatSciConsult, Munich, Germany;3. Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany;4. Boehringer Ingelheim Ltd, Bracknell, UK |
| Abstract: | |
| Keywords: | Venous thrombosis Dabigatran Rivaroxaban Indirect comparison Cost-effectiveness |